Concepts (203)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Trust | 10 | 2020 | 644 | 2.750 |
Why?
|
| Ethics, Research | 8 | 2019 | 242 | 2.260 |
Why?
|
| Public Opinion | 5 | 2019 | 283 | 1.430 |
Why?
|
| Biomedical Research | 10 | 2020 | 3409 | 1.390 |
Why?
|
| Ethics Committees, Research | 4 | 2020 | 151 | 1.240 |
Why?
|
| Science | 3 | 2014 | 280 | 1.040 |
Why?
|
| Research Subjects | 6 | 2018 | 250 | 1.020 |
Why?
|
| Ethics, Medical | 10 | 2000 | 492 | 0.720 |
Why?
|
| Disclosure | 3 | 2019 | 556 | 0.710 |
Why?
|
| Research Personnel | 3 | 2016 | 733 | 0.670 |
Why?
|
| Academic Medical Centers | 4 | 2019 | 2446 | 0.630 |
Why?
|
| Community-Institutional Relations | 2 | 2013 | 395 | 0.610 |
Why?
|
| Informed Consent | 5 | 2019 | 958 | 0.560 |
Why?
|
| Nontherapeutic Human Experimentation | 1 | 2015 | 13 | 0.500 |
Why?
|
| Marketing | 1 | 2019 | 408 | 0.490 |
Why?
|
| Therapeutic Human Experimentation | 1 | 2015 | 30 | 0.490 |
Why?
|
| Patient Advocacy | 5 | 2008 | 327 | 0.480 |
Why?
|
| Culture | 1 | 2019 | 739 | 0.480 |
Why?
|
| Social Values | 4 | 2013 | 256 | 0.470 |
Why?
|
| Patient Care | 1 | 2019 | 597 | 0.470 |
Why?
|
| Human Experimentation | 3 | 2005 | 128 | 0.460 |
Why?
|
| Patient Selection | 7 | 2015 | 4383 | 0.460 |
Why?
|
| Research | 4 | 2017 | 1937 | 0.440 |
Why?
|
| Genetic Engineering | 1 | 2019 | 882 | 0.430 |
Why?
|
| Moral Obligations | 6 | 2005 | 72 | 0.430 |
Why?
|
| Bioethics | 2 | 2020 | 140 | 0.410 |
Why?
|
| Community-Based Participatory Research | 2 | 2014 | 503 | 0.390 |
Why?
|
| Neurosciences | 1 | 2018 | 562 | 0.390 |
Why?
|
| Clinical Trials as Topic | 3 | 2018 | 7041 | 0.380 |
Why?
|
| Conflict of Interest | 3 | 2014 | 383 | 0.330 |
Why?
|
| Interdisciplinary Communication | 4 | 2015 | 768 | 0.290 |
Why?
|
| Ethics Consultation | 1 | 2018 | 46 | 0.290 |
Why?
|
| Organizational Culture | 2 | 2014 | 403 | 0.280 |
Why?
|
| Interinstitutional Relations | 2 | 2006 | 267 | 0.270 |
Why?
|
| Ethics | 2 | 2002 | 91 | 0.260 |
Why?
|
| Third-Party Consent | 2 | 2005 | 46 | 0.260 |
Why?
|
| Euthanasia, Passive | 1 | 2005 | 64 | 0.240 |
Why?
|
| Ethicists | 2 | 1997 | 55 | 0.230 |
Why?
|
| Physician's Role | 3 | 2007 | 816 | 0.230 |
Why?
|
| Mandatory Programs | 1 | 2005 | 98 | 0.230 |
Why?
|
| Vaccination | 1 | 2015 | 2863 | 0.230 |
Why?
|
| Narration | 1 | 2005 | 234 | 0.210 |
Why?
|
| Philosophy, Medical | 3 | 1993 | 39 | 0.200 |
Why?
|
| Research Support as Topic | 1 | 2006 | 580 | 0.200 |
Why?
|
| Beneficence | 4 | 1989 | 50 | 0.200 |
Why?
|
| Judgment | 1 | 2005 | 409 | 0.190 |
Why?
|
| Curriculum | 4 | 2019 | 3751 | 0.190 |
Why?
|
| Drug Industry | 1 | 2006 | 522 | 0.190 |
Why?
|
| Communication | 1 | 2014 | 3567 | 0.180 |
Why?
|
| Bioethical Issues | 4 | 2015 | 82 | 0.180 |
Why?
|
| Proxy | 1 | 2002 | 154 | 0.180 |
Why?
|
| Preventive Medicine | 1 | 2019 | 182 | 0.150 |
Why?
|
| Publication Bias | 1 | 2018 | 121 | 0.150 |
Why?
|
| Professional Misconduct | 1 | 1997 | 53 | 0.140 |
Why?
|
| Cognition Disorders | 1 | 2015 | 6959 | 0.140 |
Why?
|
| Stakeholder Participation | 1 | 2019 | 246 | 0.140 |
Why?
|
| Humans | 39 | 2020 | 707599 | 0.130 |
Why?
|
| Advisory Committees | 3 | 2013 | 732 | 0.130 |
Why?
|
| Costs and Cost Analysis | 2 | 2019 | 1341 | 0.130 |
Why?
|
| Expert Testimony | 1 | 1997 | 236 | 0.130 |
Why?
|
| Emergencies | 1 | 2020 | 914 | 0.120 |
Why?
|
| Professional Practice | 1 | 1997 | 324 | 0.120 |
Why?
|
| United States | 11 | 2019 | 64343 | 0.120 |
Why?
|
| Referral and Consultation | 1 | 2007 | 3117 | 0.120 |
Why?
|
| Metaphor | 1 | 2015 | 38 | 0.120 |
Why?
|
| Genetic Research | 1 | 2015 | 115 | 0.120 |
Why?
|
| Insurance Selection Bias | 1 | 1994 | 16 | 0.120 |
Why?
|
| Professional Role | 1 | 1997 | 416 | 0.110 |
Why?
|
| Morals | 2 | 1988 | 269 | 0.110 |
Why?
|
| Value of Life | 2 | 2005 | 75 | 0.110 |
Why?
|
| Organizational Objectives | 3 | 2002 | 415 | 0.110 |
Why?
|
| Government Regulation | 1 | 2016 | 391 | 0.110 |
Why?
|
| Capacity Building | 1 | 2014 | 224 | 0.100 |
Why?
|
| Community Participation | 1 | 2016 | 482 | 0.100 |
Why?
|
| Personal Autonomy | 4 | 2005 | 298 | 0.100 |
Why?
|
| Decision Making | 2 | 2005 | 4160 | 0.100 |
Why?
|
| Withholding Treatment | 3 | 1989 | 465 | 0.100 |
Why?
|
| Access to Information | 1 | 2014 | 266 | 0.100 |
Why?
|
| Quality Control | 1 | 2014 | 908 | 0.100 |
Why?
|
| Mental Competency | 2 | 2005 | 233 | 0.090 |
Why?
|
| Universities | 1 | 2019 | 1596 | 0.090 |
Why?
|
| Cultural Competency | 1 | 2014 | 372 | 0.090 |
Why?
|
| Role | 2 | 1993 | 190 | 0.090 |
Why?
|
| Advance Directives | 2 | 2005 | 332 | 0.090 |
Why?
|
| Alzheimer Disease | 1 | 2015 | 13563 | 0.090 |
Why?
|
| Walking | 1 | 2019 | 1830 | 0.090 |
Why?
|
| Indians, North American | 1 | 2014 | 599 | 0.090 |
Why?
|
| Genetic Counseling | 2 | 2012 | 572 | 0.080 |
Why?
|
| Bias | 1 | 2014 | 1065 | 0.080 |
Why?
|
| Semantics | 1 | 2015 | 893 | 0.080 |
Why?
|
| Terminal Care | 2 | 1989 | 975 | 0.080 |
Why?
|
| Physician-Patient Relations | 4 | 1997 | 2914 | 0.080 |
Why?
|
| Education | 1 | 2013 | 559 | 0.080 |
Why?
|
| Ornithine Carbamoyltransferase Deficiency Disease | 1 | 2009 | 49 | 0.080 |
Why?
|
| Comprehension | 1 | 2015 | 723 | 0.080 |
Why?
|
| Marketing of Health Services | 1 | 1989 | 135 | 0.080 |
Why?
|
| Life Support Care | 1 | 1989 | 189 | 0.080 |
Why?
|
| Nervous System Diseases | 1 | 2018 | 1568 | 0.080 |
Why?
|
| Colorado | 2 | 2000 | 345 | 0.070 |
Why?
|
| Neonatal Screening | 1 | 2012 | 561 | 0.070 |
Why?
|
| Terminology as Topic | 1 | 2015 | 1357 | 0.070 |
Why?
|
| Resource Allocation | 2 | 1988 | 275 | 0.070 |
Why?
|
| Students | 1 | 2019 | 2140 | 0.070 |
Why?
|
| Uncertainty | 3 | 2015 | 541 | 0.070 |
Why?
|
| Social Responsibility | 1 | 2009 | 322 | 0.070 |
Why?
|
| Fragile X Mental Retardation Protein | 1 | 2012 | 1051 | 0.070 |
Why?
|
| Hospitals, Proprietary | 1 | 1986 | 35 | 0.070 |
Why?
|
| Ethics, Institutional | 1 | 1986 | 38 | 0.070 |
Why?
|
| Models, Organizational | 1 | 2009 | 569 | 0.060 |
Why?
|
| Food | 1 | 1989 | 502 | 0.060 |
Why?
|
| Refusal to Participate | 1 | 2005 | 46 | 0.060 |
Why?
|
| Insurance, Health | 1 | 1994 | 1676 | 0.060 |
Why?
|
| Dementia | 1 | 2002 | 4640 | 0.060 |
Why?
|
| Surgery, Plastic | 1 | 1991 | 564 | 0.060 |
Why?
|
| Research Design | 2 | 2016 | 5178 | 0.060 |
Why?
|
| Sexual Behavior | 1 | 1997 | 4299 | 0.050 |
Why?
|
| Treatment Refusal | 1 | 2005 | 335 | 0.050 |
Why?
|
| Health Services for the Aged | 1 | 1986 | 432 | 0.050 |
Why?
|
| Vulnerable Populations | 2 | 2014 | 1152 | 0.050 |
Why?
|
| Genome, Human | 1 | 2015 | 3600 | 0.050 |
Why?
|
| Quality of Health Care | 2 | 1993 | 3428 | 0.050 |
Why?
|
| Dermatology | 1 | 1991 | 839 | 0.050 |
Why?
|
| Editorial Policies | 2 | 2020 | 394 | 0.050 |
Why?
|
| Legal Guardians | 1 | 2002 | 33 | 0.050 |
Why?
|
| Health | 1 | 2005 | 362 | 0.050 |
Why?
|
| Critical Care | 1 | 1993 | 2466 | 0.050 |
Why?
|
| Genetic Testing | 1 | 2012 | 2663 | 0.050 |
Why?
|
| Sexual and Gender Minorities | 1 | 2014 | 1468 | 0.050 |
Why?
|
| Fraud | 2 | 1994 | 62 | 0.050 |
Why?
|
| Collagen | 1 | 1991 | 3042 | 0.050 |
Why?
|
| Social Justice | 1 | 2005 | 362 | 0.050 |
Why?
|
| Risk Assessment | 5 | 2009 | 18593 | 0.040 |
Why?
|
| Leadership | 1 | 2009 | 1278 | 0.040 |
Why?
|
| Cost-Benefit Analysis | 2 | 1994 | 3900 | 0.040 |
Why?
|
| Healthcare Disparities | 1 | 2014 | 3093 | 0.040 |
Why?
|
| Water | 1 | 1989 | 2670 | 0.040 |
Why?
|
| Electronic Health Records | 1 | 2014 | 3332 | 0.040 |
Why?
|
| Judicial Role | 1 | 1997 | 27 | 0.040 |
Why?
|
| Physicians | 2 | 1993 | 3319 | 0.040 |
Why?
|
| Family | 1 | 1988 | 2814 | 0.030 |
Why?
|
| Genetic Therapy | 1 | 2009 | 2775 | 0.030 |
Why?
|
| Choice Behavior | 1 | 2005 | 1218 | 0.030 |
Why?
|
| Health Services Accessibility | 1 | 1994 | 5550 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2014 | 20644 | 0.030 |
Why?
|
| Policy | 1 | 2020 | 557 | 0.030 |
Why?
|
| Health Services Needs and Demand | 2 | 1994 | 1646 | 0.030 |
Why?
|
| Journalism, Medical | 1 | 2015 | 44 | 0.030 |
Why?
|
| Newspapers as Topic | 1 | 2015 | 53 | 0.030 |
Why?
|
| Alaska | 1 | 2014 | 186 | 0.030 |
Why?
|
| Teaching | 1 | 2002 | 1190 | 0.030 |
Why?
|
| Hospitals | 1 | 1986 | 2666 | 0.030 |
Why?
|
| Psycholinguistics | 1 | 2015 | 162 | 0.030 |
Why?
|
| Guidelines as Topic | 1 | 2019 | 1369 | 0.030 |
Why?
|
| Health Priorities | 1 | 1993 | 322 | 0.020 |
Why?
|
| Interprofessional Relations | 1 | 1997 | 911 | 0.020 |
Why?
|
| Injections, Intradermal | 1 | 1991 | 156 | 0.020 |
Why?
|
| Social Control, Formal | 1 | 1990 | 112 | 0.020 |
Why?
|
| Clustered Regularly Interspaced Short Palindromic Repeats | 1 | 2015 | 519 | 0.020 |
Why?
|
| Paternalism | 1 | 1989 | 25 | 0.020 |
Why?
|
| Mutation | 1 | 2012 | 25365 | 0.020 |
Why?
|
| Attitude of Health Personnel | 2 | 2014 | 3916 | 0.020 |
Why?
|
| Technology Assessment, Biomedical | 1 | 1990 | 242 | 0.020 |
Why?
|
| Economic Competition | 1 | 1989 | 136 | 0.020 |
Why?
|
| Foundations | 1 | 2008 | 134 | 0.020 |
Why?
|
| Germ-Line Mutation | 1 | 2015 | 1228 | 0.020 |
Why?
|
| alpha 1-Antitrypsin Deficiency | 1 | 2008 | 83 | 0.020 |
Why?
|
| Cooperative Behavior | 1 | 2016 | 1726 | 0.020 |
Why?
|
| Personhood | 1 | 1988 | 39 | 0.020 |
Why?
|
| Gender Identity | 1 | 2014 | 842 | 0.020 |
Why?
|
| Evaluation Studies as Topic | 1 | 1989 | 1403 | 0.020 |
Why?
|
| Malpractice | 1 | 1989 | 232 | 0.020 |
Why?
|
| Male | 4 | 2015 | 361235 | 0.020 |
Why?
|
| Consumer Behavior | 1 | 1989 | 435 | 0.020 |
Why?
|
| Pedigree | 1 | 2012 | 3413 | 0.020 |
Why?
|
| Female | 4 | 2015 | 378021 | 0.020 |
Why?
|
| Heterozygote | 1 | 2012 | 2642 | 0.020 |
Why?
|
| Learning | 1 | 2019 | 3101 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2012 | 2903 | 0.020 |
Why?
|
| Stress, Psychological | 2 | 2014 | 5474 | 0.020 |
Why?
|
| Animals | 1 | 2018 | 224480 | 0.010 |
Why?
|
| Professional-Family Relations | 1 | 1986 | 365 | 0.010 |
Why?
|
| Patient Care Team | 1 | 1993 | 2125 | 0.010 |
Why?
|
| Aged | 3 | 2005 | 154705 | 0.010 |
Why?
|
| Fragile X Syndrome | 1 | 2012 | 1444 | 0.010 |
Why?
|
| Social Support | 1 | 2014 | 3191 | 0.010 |
Why?
|
| Huntington Disease | 1 | 1989 | 893 | 0.010 |
Why?
|
| Attitude to Health | 1 | 1990 | 2222 | 0.010 |
Why?
|
| Patient Satisfaction | 1 | 1994 | 3615 | 0.010 |
Why?
|
| Cerebrovascular Disorders | 1 | 1986 | 990 | 0.010 |
Why?
|
| Patient Participation | 1 | 1989 | 1654 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2012 | 8513 | 0.010 |
Why?
|
| Patient Education as Topic | 1 | 1989 | 3021 | 0.010 |
Why?
|
| Health Promotion | 1 | 1989 | 2704 | 0.010 |
Why?
|
| Clinical Competence | 1 | 1989 | 4904 | 0.010 |
Why?
|
| Delivery of Health Care | 1 | 1989 | 4150 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2012 | 22124 | 0.010 |
Why?
|
| Middle Aged | 2 | 2002 | 201528 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2012 | 29652 | 0.010 |
Why?
|
| Age Factors | 1 | 1986 | 17351 | 0.010 |
Why?
|
| Adult | 1 | 2002 | 205108 | 0.000 |
Why?
|
| Prognosis | 1 | 1986 | 23835 | 0.000 |
Why?
|
| Risk Factors | 1 | 2012 | 57542 | 0.000 |
Why?
|
| Quality of Life | 1 | 1986 | 13572 | 0.000 |
Why?
|